Scientists Discover How Cholesterol Receptor Helps Hepatitis A Virus Enter Cells
New research reveals the LDLR cholesterol receptor facilitates hepatitis A virus entry, opening potential therapeutic targets.
Summary
Scientists have identified how hepatitis A virus enters human cells, discovering that the low-density lipoprotein receptor (LDLR) - the same protein that helps cells absorb cholesterol - serves as a gateway for the virus. Using advanced microscopy and genetic techniques, researchers found that blocking LDLR prevented viral entry without affecting the virus's ability to attach to cells. This breakthrough explains a long-standing mystery about hepatitis A infection mechanisms and could lead to new antiviral treatments that target this cellular entry point.
Detailed Summary
This groundbreaking study solves a decades-old puzzle about how hepatitis A virus infects human cells, potentially opening new avenues for antiviral drug development and improving our understanding of viral infections.
Researchers investigated hepatitis A virus, which exists in two forms: non-enveloped particles shed in feces and quasi-enveloped particles in blood. While scientists knew how the blood form entered cells, the mechanism for the fecal form remained unknown.
Using knockout cell lines, advanced electron microscopy, and binding assays, scientists tested whether the low-density lipoprotein receptor (LDLR) - famous for cholesterol metabolism - might serve as an entry point. They created cells lacking LDLR and tested viral infection rates.
The results were striking: LDLR knockout completely blocked non-enveloped hepatitis A virus entry without affecting viral attachment. Restoring LDLR expression rescued viral entry, while blocking LDLR with antibodies or soluble receptor fragments prevented infection. High-resolution imaging revealed the virus binds to specific regions of LDLR.
This discovery has significant implications for antiviral drug development, as LDLR could become a therapeutic target. Understanding viral entry mechanisms also advances our knowledge of how pathogens exploit normal cellular processes. However, the research was conducted in laboratory cell cultures, and real-world applications require further study. The findings primarily apply to hepatitis A prevention rather than longevity enhancement, though they contribute to our broader understanding of cellular biology and infection prevention strategies.
Key Findings
- LDLR cholesterol receptor serves as entry gateway for non-enveloped hepatitis A virus
- Blocking LDLR prevents viral infection without affecting virus attachment to cells
- Virus binds to specific LDLR regions at the capsid's fivefold vertex
- Discovery opens potential for new antiviral drugs targeting cellular entry
Methodology
Researchers used LDLR knockout cell lines, cryo-electron microscopy at 1.7Å resolution, binding assays, and genetic rescue experiments. Study employed multiple complementary approaches including antibody blocking, soluble receptor competition, and structural analysis.
Study Limitations
Research conducted only in laboratory cell cultures, not human subjects. Clinical applications require extensive further testing. Findings specific to hepatitis A may not apply to other viral infections.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.